StockData
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Yubo International Biotech Ltd

Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$886.19K
P/E (TTM)
–
Dividend yield
–

About Yubo International Biotech

Electromedical & Electrotherapeutic Apparatus, SIC 3845

The company is a biotechnology enterprise that focuses on the research, development, and commercial application of endometrial stem cells. Through its Chinese operating affiliate, it markets various consumer goods under the VIVCELL brand name, including skincare, hair care, respiratory healthcare products, healthy beverages, and personal care items for men and women. In addition to physical goods, the business provides specialized stem cell solutions such as cell testing and health management consulting. Its customer base consists of individual consumers who purchase its personal healthcare items and clients who utilize its diagnostic and wellness advisory services.

The enterprise conducts its day-to-day operations in the People's Republic of China, maintaining operational and administrative entities in locations including Beijing, Chengdu, Shenzhen, and Hong Kong. The organization is structured as a United States holding company that directs its Chinese business activities through contractual arrangements with domestic entities rather than direct equity ownership. All executive officers and directors are based in China, where substantially all corporate activities and operational assets are situated.

Summary of the business section of Yubo International Biotech's latest annual report, written by StockData.

Company profile

Company

Legal name
Yubo International Biotech Ltd
Headquarters
Beijing, F4
Address
Room 105, Building 5, 31 Xishiku Avenue 00000
Phone
86 (010) 6615-5141
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
New York
Fiscal year ends
December 31
Auditor
HCL PLLC, Chicago, IL

Stock & identifiers

Ticker
YBGJ
Exchange
OTC
IPO date
Aug 24, 2021
Shares outstanding
170M, Aug 11, 2026
Public float
$1, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
895464
CUSIP
988366100
ISIN
US9883661004
EIN
11-3074326

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yang WangChief Executive Officer, Director25,811,400
Jun WangPresident, Director81,943,800
Nanping HuDirector0

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 16, 2026Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 10, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 6, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 13, 2024Late filingNotification of late filing
May 13, 2024Late filingNotification of late filing
Mar 28, 2024Late filingNotification of late filing
Nov 13, 2023Late filingNotification of late filing
Mar 28, 2023Late filingNotification of late filing
Nov 14, 2022Late filingNotification of late filing
Mar 24, 2022Late filingNotification of late filing
Aug 16, 2021Late filingNotification of late filing
May 14, 2021Late filingNotification of late filing
Jan 15, 2021Late filingNotification of late filing
Jan 14, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 4, 2020Name changeName changed from MAGNA LAB INC to Yubo International Biotech Ltd
Oct 16, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Oct 15, 2020Late filingNotification of late filing
Jul 15, 2020Late filingNotification of late filing
May 30, 2019Late filingNotification of late filing
May 30, 2018Late filingNotification of late filing
May 30, 2017Late filingNotification of late filing
May 31, 2016Late filingNotification of late filing
Jan 11, 2016Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 24, 2015Auditor changeChange in certifying accountant (8-K Item 4.01)
May 29, 2015Late filingNotification of late filing
Oct 15, 2014Late filingNotification of late filing
Jul 3, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
May 29, 2014Late filingNotification of late filing
May 29, 2013Late filingNotification of late filing
Jan 15, 2013Late filingNotification of late filing